Viewpoints of dentists on the use of bisphosphonates in rheumatology patients
Objectives: Alhough typically prescribed in oncology, bisphosphonates (BPs) are also employed in rheumatology, particularly for the treatment of osteoporosis, sometimes resulting in complications, such as osteonecrosis of the jaw. Because of different opinions between rheumatologists and dentists on...
Main Authors: | Daron, C. (Author), Deschaumes, C. (Author), Mathieu, S. (Author), Soubrier, M. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley-Blackwell Publishing Ltd
2018
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
The awareness and practice of dentists regarding medication-related osteonecrosis of the jaw and its prevention: a cross-sectional survey
by: A. Lum Han
Published: (2021-03-01) -
Development of Osteonecrosis of the Jaw in a Patient Receiving Oral Bisphosphonates for Osteoporosis: A Case Report
by: Sina Esmaeilzadeh, et al.
Published: (2014-08-01) -
Bisphosphonate associated osteomyelitis of the jaw in patients with bony exposure: prevention, a new way of thinking
by: Arezo TARDAST, et al.
Published: (2015-06-01) -
Dental Implant Placement in Patients on Bisphosphonate Therapy: a Systematic Review
by: Rokas Gelazius, et al.
Published: (2018-10-01) -
Implant therapy on patients treated with oral bisphosphonates
by: Aris Petros Tripodakis, et al.
Published: (2012-03-01)